The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Molecular mechanism(s) of resistance to vandetanib in medullary thyroid carcinoma.

Brittany  Glassberg

No Relationships to Disclose

Sophia  Khan

No Relationships to Disclose

Alex  Pemov

No Relationships to Disclose

Robert  Hawley

No Relationships to Disclose

Brigitte C.  Widemann

No Relationships to Disclose

Javed  Khan

Patents, Royalties, Other Intellectual Property - Monoclonal antibody-based therapeutics targeting fibroblast growth factor receptor 4 (FGFR4) for potential treatment of human cancers expressing FGFR4

John  Glod

Research Funding - AdaptImmune; GlaxoSmithKline/Adaptimmune (Inst)